These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. Cao B; Wang H; Sun H; Zhu Y; Chen M J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240 [TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital. Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070 [TBL] [Abstract][Full Text] [Related]
12. [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa]. Cao B; Wang H; Zhu YJ; Chen MJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):31-5. PubMed ID: 14989823 [TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Eagye KJ; Kuti JL; Nicolau DP Infect Control Hosp Epidemiol; 2009 Aug; 30(8):746-52. PubMed ID: 19583513 [TBL] [Abstract][Full Text] [Related]
15. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa. Ray GT; Baxter R; DeLorenze GN Clin Infect Dis; 2005 Aug; 41(4):441-9. PubMed ID: 16028150 [TBL] [Abstract][Full Text] [Related]
17. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923 [TBL] [Abstract][Full Text] [Related]
18. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa. Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158 [TBL] [Abstract][Full Text] [Related]
19. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005. Babay HA Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]